AP NEWS

Europe Psoriatic Arthritis Market and Competitive Landscape 2018-2023 - ResearchAndMarkets.com

December 5, 2018

DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The “Europe Psoriatic Arthritis Market and Competitive Landscape 2018-2023” report has been added to ResearchAndMarkets.com’s offering.

Europe Psoriatic Arthritis Market and Competitive Landscape 2018-2023, provides comprehensive insights into Psoriatic Arthritis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.This study accurately estimates and forecast Psoriatic Arthritis market size and drug sales. This research also provides insights into Psoriatic Arthritis epidemiology and late stage pipeline.

The research is classified into following sections - Psoriatic Arthritis overview with definitions, symptoms, etiology, diagnosis, treatment options; Psoriatic Arthritis pipeline insights covering late stage clinical trials pipeline; Psoriatic Arthritis prevalence trends by countries; Psoriatic Arthritis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Key Topics Covered

1. Psoriatic Arthritis: Disease Overview

2. Psoriatic Arthritis Pipeline Insights

3. Psoriatic Arthritis Epidemiology Analysis

4. Germany Psoriatic Arthritis Market Insights

5. France Psoriatic Arthritis Market Insights

6. Italy Psoriatic Arthritis Market Insights

7. Spain Psoriatic Arthritis Market Insights

8. UK Psoriatic Arthritis Market Insights

9. Europe Psoriatic Arthritis Market Insights

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/qpb94s/europe_psoriatic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005365/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs,Musculoskeletal Disorders Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/05/2018 07:24 AM/DISC: 12/05/2018 07:24 AM

http://www.businesswire.com/news/home/20181205005365/en

AP RADIO
Update hourly